$AVRW
Avenir Wellness Solutions, Inc. Stock $avrw

$avrw Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000147793222006612 Filed on September 02, 2022

Income Statement

Concept	2022 Q3	2022 Q2
Revenue	$1.784M	$1.123M
YoY Change	31.27%	-46.75%
Cost Of Revenue	$356.0K	$150.0K
YoY Change	-30.47%	-81.18%
Gross Profit	$1.428M	$973.0K
YoY Change	68.6%	-25.84%
Gross Profit Margin	80.04%	86.64%
Selling, General & Admin	$3.612M	$3.120M
YoY Change	-21.2%	-34.62%
% of Gross Profit	252.94%	320.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$0.00	$500.00
YoY Change	-100.0%	-98.75%
% of Gross Profit	0.0%	0.05%
Operating Expenses	$3.933M	$7.753M
YoY Change	-32.11%	69.39%
Operating Profit	-$2.506M	-$6.780M
YoY Change	-49.33%	107.66%
Interest Expense	$6.000K	$191.0K
YoY Change	-103.41%	-243.61%
% of Operating Profit
Other Income/Expense, Net	-$403.0K	-$151.0K
YoY Change	-166.83%	-107.77%
Pretax Income	-$2.909M	-$6.931M
YoY Change	-33.02%	424.68%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$3.593M	-$9.619M
YoY Change	-17.27%	628.16%
Net Earnings / Revenue	-201.4%	-856.54%
Basic Earnings Per Share
Diluted Earnings Per Share	-$50.83K	-$137.7K
COMMON SHARES
Basic Shares Outstanding	71.14M shares	69.87M shares
Diluted Shares Outstanding		69.87M shares

Balance Sheet

Concept	2022 Q3	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.443M	$51.00K
YoY Change	2609.15%	-97.0%
Cash & Equivalents	$4.443M	$51.00K
Short-Term Investments
Other Short-Term Assets	$58.00K	$120.0K
YoY Change	-86.54%	-2.44%
Inventory	$640.0K	$649.0K
Prepaid Expenses	$359.0K	$18.00K
Receivables	$460.0K	$545.0K
Other Receivables	$2.200M	$0.00
Total Short-Term Assets	$8.251M	$20.18M
YoY Change	368.01%	513.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.000K	$3.000K
YoY Change	-99.84%	-99.85%
Goodwill	$4.690M	$4.690M
YoY Change	-66.18%	-66.18%
Intangibles	$248.0K	$252.0K
YoY Change	-98.35%	-97.88%
Long-Term Investments	$216.0K	$216.0K
YoY Change	-57.56%	-57.56%
Other Assets	$71.00K	$2.050M
YoY Change	-14.46%	2369.88%
Total Long-Term Assets	$6.713M	$9.139M
YoY Change	-83.27%	-77.79%
TOTAL ASSETS
Total Short-Term Assets	$8.251M	$20.18M
Total Long-Term Assets	$6.713M	$9.139M
Total Assets	$14.96M	$29.32M
YoY Change	-64.27%	-34.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.630M	$3.153M
YoY Change	-27.3%	56.48%
Accrued Expenses	$1.431M	$2.851M
YoY Change	-67.47%	-25.13%
Deferred Revenue
YoY Change
Short-Term Debt	$588.0K	$3.727M
YoY Change	-75.6%	73.67%
Long-Term Debt Due	$9.984M	$11.82M
YoY Change	24.24%	39.45%
Total Short-Term Liabilities	$15.06M	$26.32M
YoY Change	-14.93%	54.46%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$81.00K	$110.0K
YoY Change	-96.7%	-94.14%
Total Long-Term Liabilities	$81.00K	$110.0K
YoY Change	-98.55%	-98.23%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.06M	$26.32M
Total Long-Term Liabilities	$81.00K	$110.0K
Total Liabilities	$15.14M	$26.43M
YoY Change	-35.02%	13.73%
SHAREHOLDERS EQUITY
Retained Earnings	-$112.8M	-$109.2M
YoY Change	25.22%	27.37%
Common Stock	$71.00K	$71.00K
YoY Change	7.58%	12.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$173.0K	$2.888M
YoY Change
Total Liabilities & Shareholders Equity	$14.96M	$29.32M
YoY Change	-64.27%	-34.02%

Cashflow Statement

Concept	2022 Q3	2022 Q2
OPERATING ACTIVITIES
Net Income	-$3.593M	-$9.619M
YoY Change	-17.27%	628.16%
Depreciation, Depletion And Amortization	$0.00	$500.00
YoY Change	-100.0%	-98.75%
Cash From Operating Activities	-$4.917M	-$1.736M
YoY Change	145.85%	-255.14%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$13.89M	$0.00
YoY Change		-100.0%
Cash From Investing Activities	$13.89M	$0.00
YoY Change	-1389200.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-4.582M	1.256M
YoY Change	-1087.5%	269.41%
NET CHANGE
Cash From Operating Activities	-4.917M	-1.736M
Cash From Investing Activities	13.89M	0.000
Cash From Financing Activities	-4.582M	1.256M
Net Change In Cash	4.392M	-480.0K
YoY Change	-385.75%	-139.31%
FREE CASH FLOW
Cash From Operating Activities	-$4.917M	-$1.736M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1781000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	210000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	257000	usd
CY2022Q2	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	200000	usd
CY2021Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	200000	usd
CY2022Q2	curr	Customer Relationships Tradename And Non Compete Net CustomerRelationshipsTradenameAndNonCompeteNet	1518000	usd
	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.09
	dei	Entity Central Index Key EntityCentralIndexKey	0001643301
CY2021Q4	us-gaap	Goodwill Goodwill	4690000	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	70011900	shares
CY2021	curr	Contract Liabilities Ending Balance ContractLiabilitiesEndingBalance	293000	usd
	curr	Purchase Of Convertible Loans PurchaseOfConvertibleLoans	500000.0	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	261000	usd
	curr	Other Research And Development OtherResearchAndDevelopment	300000.0	usd
	curr	Medolife To Pay MedolifeToPay	300000.0	usd
CY2022Q2	us-gaap	Advertising Expense AdvertisingExpense	80000.00	usd
CY2021Q1	curr	Interest Rate InterestRate	0.1	pure
CY2020Q3	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	1100000	usd
CY2022Q2	curr	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding And Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstandingAndExercisable	0	usd
CY2021Q2	curr	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding And Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstandingAndExercisable	0	usd
	curr	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding And Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstandingAndExercisable	0	usd
CY2021Q4	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	70011900	shares
	curr	Fair Value At December312021 FairValueAtDecember312021	1430000	usd
CY2021	curr	Weighted Average Remaining Lease Term Operating Lease WeightedAverageRemainingLeaseTermOperatingLease	P2Y3M15D
	curr	Weighted Average Remaining Lease Term Operating Lease WeightedAverageRemainingLeaseTermOperatingLease	P1Y11M1D
	curr	Gross Sum Relating To Deferred Payroll GrossSumRelatingToDeferredPayroll	10000.00	usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	333-204857
	dei	Entity Registrant Name EntityRegistrantName	CURE PHARMACEUTICAL HOLDING CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	37-1765151
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5805 Sepulveda Blvd
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 801
	dei	Entity Address City Or Town EntityAddressCityOrTown	Sherman Oaks
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	91411
	dei	City Area Code CityAreaCode	424
	dei	Local Phone Number LocalPhoneNumber	273-8675
	dei	Security12g Title Security12gTitle	Common stock, par value $0.001
	dei	Trading Symbol TradingSymbol	CURR
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	71141505	shares
CY2022Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	18564000	usd
CY2021Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	340000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	20178000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	4690000	usd
CY2021Q4	curr	Customer Relationships Tradename And Non Compete Net CustomerRelationshipsTradenameAndNonCompeteNet	7297000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	48000	usd
CY2022Q2	curr	Long Term Assets Held For Sale LongTermAssetsHeldForSale	2000000	usd
CY2021Q4	curr	Long Term Assets Held For Sale LongTermAssetsHeldForSale	25820000	usd
CY2022Q2	us-gaap	Assets Assets	29317000	usd
CY2021Q4	us-gaap	Assets Assets	40574000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3153000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2848000	usd
CY2022Q2	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	2734000	usd
CY2021Q4	us-gaap	Accrued Utilities Current AccruedUtilitiesCurrent	3485000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	117000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	104000	usd
CY2022Q2	us-gaap	Loans Payable LoansPayable	48000	usd
CY2021Q4	us-gaap	Loans Payable LoansPayable	235000	usd
CY2022Q2	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	2243000	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	2011000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	3129000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2877000	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	550000	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	550000	usd
CY2022Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	9573000	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	9932000	usd
CY2022Q2	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	172000	usd
CY2021Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	293000	usd
CY2022Q2	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	595000	usd
CY2021Q4	us-gaap	Contingent Consideration Classified As Equity Fair Value Disclosure ContingentConsiderationClassifiedAsEquityFairValueDisclosure	1430000	usd
CY2022Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	4005000	usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	496000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	26319000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	24261000	usd
CY2022Q2	curr	Operating Lease Payable OperatingLeasePayable	110000	usd
CY2021Q4	curr	Operating Lease Payable OperatingLeasePayable	174000	usd
CY2022Q2	curr	Long Term Liabilities Held For Sale LongTermLiabilitiesHeldForSale	0	usd
CY2021Q4	curr	Long Term Liabilities Held For Sale LongTermLiabilitiesHeldForSale	27000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	26429000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	24462000	usd
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	70011900	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	71000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	69000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	111725000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	110146000	usd
CY2022Q2	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	308000	usd
CY2021Q4	us-gaap	Common Unit Issuance Value CommonUnitIssuanceValue	343000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-109216000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-94446000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2888000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16112000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29317000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	40574000	usd
CY2022Q2	curr	Product Sales Net Of Discounts And Refunds ProductSalesNetOfDiscountsAndRefunds	1123000	usd
CY2021Q2	curr	Product Sales Net Of Discounts And Refunds ProductSalesNetOfDiscountsAndRefunds	2067000	usd
	curr	Product Sales Net Of Discounts And Refunds ProductSalesNetOfDiscountsAndRefunds	2199000	usd
CY2022Q2	curr	Shipping And Other Sales ShippingAndOtherSales	0	usd
CY2021Q2	curr	Shipping And Other Sales ShippingAndOtherSales	1000	usd
	curr	Shipping And Other Sales ShippingAndOtherSales	17000	usd
CY2021Q2	us-gaap	Revenues Revenues	2068000	usd
	us-gaap	Revenues Revenues	2199000	usd
	us-gaap	Revenues Revenues	3329000	usd
CY2022Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	150000	usd
CY2021Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	748000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	487000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1033000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	973000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	1320000	usd
	us-gaap	Gross Profit GrossProfit	1712000	usd
	us-gaap	Gross Profit GrossProfit	2296000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3120000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4465000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5869000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	9966000	usd
CY2022Q2	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	11000	usd
CY2021Q2	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	-893000	usd
	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	-835000	usd
	curr	Change In Fair Value Of Contingent Stock Consideration ChangeInFairValueOfContingentStockConsideration	-1555000	usd
CY2022Q2	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	4622000	usd
CY2021Q2	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	usd
	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	4622000	usd
	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	7753000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	3572000	usd
	us-gaap	Operating Expenses OperatingExpenses	9656000	usd
	us-gaap	Operating Expenses OperatingExpenses	8411000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-6780000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-2252000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7944000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6115000	usd
CY2022Q2	us-gaap	Interest Income Operating InterestIncomeOperating	1000	usd
CY2021Q2	us-gaap	Interest Income Operating InterestIncomeOperating	0	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	3000	usd
	us-gaap	Interest Income Operating InterestIncomeOperating	2000	usd
CY2022Q2	curr	Gain Loss From Settlement GainLossFromSettlement	0	usd
CY2021Q2	curr	Gain Loss From Settlement GainLossFromSettlement	2434000	usd
	curr	Gain Loss From Settlement GainLossFromSettlement	82000	usd
	curr	Gain Loss From Settlement GainLossFromSettlement	2434000	usd
CY2022Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	40000	usd
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	335000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	40000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	734000	usd
CY2022Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2021Q2	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-41000	usd
CY2022Q2	curr	Change In Fair Value Of Convertible Promissory Notes ChangeInFairValueOfConvertiblePromissoryNotes	-27000	usd
CY2021Q2	curr	Change In Fair Value Of Convertible Promissory Notes ChangeInFairValueOfConvertiblePromissoryNotes	-692000	usd
	curr	Change In Fair Value Of Convertible Promissory Notes ChangeInFairValueOfConvertiblePromissoryNotes	-307000	usd
	curr	Change In Fair Value Of Convertible Promissory Notes ChangeInFairValueOfConvertiblePromissoryNotes	340000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	191000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	135000	usd
	us-gaap	Interest Expense InterestExpense	387000	usd
	us-gaap	Interest Expense InterestExpense	199000	usd
CY2022Q2	us-gaap	Other Income OtherIncome	26000	usd
CY2021Q2	us-gaap	Other Income OtherIncome	0	usd
	us-gaap	Other Income OtherIncome	26000	usd
	us-gaap	Other Income OtherIncome	0	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-151000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1942000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-543000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3270000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-6931000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-310000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-8487000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2845000	usd
CY2022Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2021Q2	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6931000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-310000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8487000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2845000	usd
CY2022Q2	curr	Loss Before Provision For Income Taxes LossBeforeProvisionForIncomeTaxes	-2688000	usd
CY2021Q2	curr	Loss Before Provision For Income Taxes LossBeforeProvisionForIncomeTaxes	-1011000	usd
	curr	Loss Before Provision For Income Taxes LossBeforeProvisionForIncomeTaxes	-6283000	usd
	curr	Loss Before Provision For Income Taxes LossBeforeProvisionForIncomeTaxes	-1647000	usd
CY2022Q2	curr	Provision For Income Taxes Disposal Group ProvisionForIncomeTaxesDisposalGroup	0	usd
CY2021Q2	curr	Provision For Income Taxes Disposal Group ProvisionForIncomeTaxesDisposalGroup	0	usd
	curr	Provision For Income Taxes Disposal Group ProvisionForIncomeTaxesDisposalGroup	0	usd
	curr	Provision For Income Taxes Disposal Group ProvisionForIncomeTaxesDisposalGroup	0	usd
CY2022Q2	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-2688000	usd
CY2021Q2	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-1011000	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-6283000	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-1647000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-9619000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1321000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-14770000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4492000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.10
CY2021Q2	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.00
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.12
	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	-0.06
CY2022Q2	curr	Disposal Group DisposalGroup	-0.04
CY2021Q2	curr	Disposal Group DisposalGroup	-0.02
	curr	Disposal Group DisposalGroup	-0.09
	curr	Disposal Group DisposalGroup	-0.03
CY2022Q2	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.14
CY2021Q2	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.02
	curr	Income Loss From Continuing Operations Per Basic And Diluted Share1 IncomeLossFromContinuingOperationsPerBasicAndDilutedShare1	-0.21
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69868502	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	59842904	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	69362563	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48299751	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69868502	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	59842904	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	69362563	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48299751	shares
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16112000	usd
CY2022Q1	curr	Issuance Of Common Stock For Professional Servicesamount IssuanceOfCommonStockForProfessionalServicesamount	17000	usd
CY2022Q1	curr	Issuance Of Common Stock From Conversion Of Convertible Promissory Notes Amount IssuanceOfCommonStockFromConversionOfConvertiblePromissoryNotesAmount	666000	usd
CY2022Q1	curr	Fair Value Of Stock Options And Restricted Stock Granted FairValueOfStockOptionsAndRestrictedStockGranted	103000	usd
CY2022Q1	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	352000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-5151000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	12099000	usd
CY2022Q2	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	-10000	usd
CY2022Q2	curr	Fair Value Of Stock Options And Restricted Stock Granted FairValueOfStockOptionsAndRestrictedStockGranted	102000	usd
CY2022Q2	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	316000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-9619000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2888000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	21279000	usd
CY2021Q1	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	508000	usd
CY2021Q1	curr	Issuance Of Common Stock From The Equity Incentive Plan Amount IssuanceOfCommonStockFromTheEquityIncentivePlanAmount	138000	usd
CY2021Q1	curr	Issuance Of Common Stock For Exercise Of Warrants Amount IssuanceOfCommonStockForExerciseOfWarrantsAmount	0	usd
CY2021Q1	curr	Fair Value Of Stock Options And Restricted Stock Granted FairValueOfStockOptionsAndRestrictedStockGranted	961000	usd
CY2021Q2	curr	Issuance Of Common Stock For Professional Services Amount IssuanceOfCommonStockForProfessionalServicesAmount	243000	usd
CY2021Q2	curr	Issuance Of Common Stock From The Equity Incentive Plan Amount IssuanceOfCommonStockFromTheEquityIncentivePlanAmount	-157000	usd
CY2021Q2	curr	Issuance Of Common Stock From Conversion Of Convertible Promissory Notes Amount IssuanceOfCommonStockFromConversionOfConvertiblePromissoryNotesAmount	1835000	usd
CY2021Q2	curr	Fair Value Of Stock Options And Restricted Stock Granted FairValueOfStockOptionsAndRestrictedStockGranted	591000	usd
CY2021Q2	curr	Fair Value Of Restricted Stock Units Granted FairValueOfRestrictedStockUnitsGranted	143000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-1321000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	21193000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8487000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2845000	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-6283000	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-1647000	usd
	us-gaap	Profit Loss ProfitLoss	-14770000	usd
	us-gaap	Profit Loss ProfitLoss	-4492000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	7000	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	752000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-19000	usd
	curr	Gain From Extinguishment Of Debt GainFromExtinguishmentOfDebt	40000	usd
	curr	Gain From Extinguishment Of Debt GainFromExtinguishmentOfDebt	734000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-835000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Asset1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1	-1555000	usd
	curr	Change In Fair Value Of Convertible Promissory Notes ChangeInFairValueOfConvertiblePromissoryNotes	-307000	usd
	curr	Change In Fair Value Of Convertible Promissory Notes ChangeInFairValueOfConvertiblePromissoryNotes	340000	usd
	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	4622000	usd
	us-gaap	Tangible Asset Impairment Charges TangibleAssetImpairmentCharges	0	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1167000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1163000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	47000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	42000	usd
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	0	usd
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	6000	usd
	us-gaap	Recovery Of Direct Costs RecoveryOfDirectCosts	0	usd
	us-gaap	Recovery Of Direct Costs RecoveryOfDirectCosts	221000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	6000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	3000	usd
	curr	Fair Value Of Vested Stock Options And Restricted Stock FairValueOfVestedStockOptionsAndRestrictedStock	873000	usd
	curr	Fair Value Of Vested Stock Options And Restricted Stock FairValueOfVestedStockOptionsAndRestrictedStock	1839000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-188000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-24000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-34000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-257000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	78000	usd
	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	903000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-25000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	345000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-120000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-709000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2687000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-51000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-44000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-121000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-612000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	5728000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	392000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3570000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-656000	usd
	curr	Cash Used In Investing Activities Of Disposal Group CashUsedInInvestingActivitiesOfDisposalGroup	0	usd
	curr	Cash Used In Investing Activities Of Disposal Group CashUsedInInvestingActivitiesOfDisposalGroup	99000	usd
	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	0	usd
	us-gaap	Increase Decrease In Notes Receivable Current IncreaseDecreaseInNotesReceivableCurrent	200000	usd
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	0	usd
	us-gaap	Proceeds From Sale And Collection Of Notes Receivable ProceedsFromSaleAndCollectionOfNotesReceivable	200000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-99000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	252000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	750000	usd
	curr	Proceeds From Notes Payable Of Disposal Group ProceedsFromNotesPayableOfDisposalGroup	3350000	usd
	curr	Proceeds From Notes Payable Of Disposal Group ProceedsFromNotesPayableOfDisposalGroup	0	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	190000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	200000	usd
	us-gaap	Payments For Loans PaymentsForLoans	187000	usd
	us-gaap	Payments For Loans PaymentsForLoans	219000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3605000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	731000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	35000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-24000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1725000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	51000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1701000	usd
	us-gaap	Interest Paid Net InterestPaidNet	50000	usd
	us-gaap	Interest Paid Net InterestPaidNet	68000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
	curr	Common Stock Issued For Conversion Of Promissory Notes And Accrued Interest CommonStockIssuedForConversionOfPromissoryNotesAndAccruedInterest	666000	usd
	curr	Common Stock Issued For Conversion Of Promissory Notes And Accrued Interest CommonStockIssuedForConversionOfPromissoryNotesAndAccruedInterest	1835000	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	42000	usd
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	0	usd
	us-gaap	Basis Of Accounting BasisOfAccounting	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”). The summary of significant accounting policies presented below is designed to assist in understanding the Company’s financial statements. Such financial statements and accompanying notes are the representations of Company’s management, who is responsible for their integrity and objectivity.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with GAAP for interim financial statements and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (“SEC”). Accordingly, they do not contain all information and footnotes required by GAAP for annual financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of June 30, 2022, and the results of operations and cash flows for the periods presented. The results of operations for the three and six months ended June 30, 2022 and 2021, are not necessarily indicative of the operating results for the full fiscal year or any future period, given the recent completion of the Asset Sale. These unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and related notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed with the SEC on April 1, 2022 (our “2021 Annual Report”).</p>
CY2022Q2	us-gaap	Cash Cash	50000.00	usd
CY2022Q2	curr	Accumulated Deficit AccumulatedDeficit	-107220000	usd
CY2022Q2	curr	Working Capital Deficit WorkingCapitalDeficit	2140000	usd
	us-gaap	Reclassifications Reclassifications	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Certain reclassifications have been made to prior year’s consolidated financial statements to enhance comparability with the current year’s consolidated financial statements. These reclassifications had no effect on the previously reported net loss.</p>
	us-gaap	Use Of Estimates UseOfEstimates	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 33.75pt; text-align:justify;">The preparation of the accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reported period. Management bases these estimates and assumptions upon historical experience, existing and known circumstances, authoritative accounting pronouncements, and other factors that management believes to be reasonable. In addition, the Company has considered the potential impact of the COVID-19 pandemic, as well as certain macroeconomic factors, including inflation, rising interest rates, and recessionary pressures, on its business and operations. Although the full impact of these factors are unknown and cannot be reasonably estimated, the Company believes it has made appropriate accounting estimates and assumptions based on the facts and circumstances available as of the reporting date.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="font-size:10pt;font-family:times new roman;margin:0px">Significant areas requiring the use of management estimates include, but are not limited to, revenue recognition, the allowance for doubtful accounts, valuation of intangible assets and goodwill, depreciative and amortization useful lives, assumptions used to calculate the fair value of the contingent share consideration, stock based compensation, beneficial conversion features, warrant values, deferred taxes and the assumptions used to calculate derivative liabilities and fair values of the purchase price allocations and convertible promissory notes. Actual results could differ materially from such estimates under different assumptions or circumstances.</p>
CY2022Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2022Q2	curr	Customer Deposits For Commercial Products CustomerDepositsForCommercialProducts	172000	usd
CY2021Q4	curr	Customer Deposits For Commercial Products CustomerDepositsForCommercialProducts	293000	usd
CY2022Q2	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	172000	usd
CY2021Q4	us-gaap	Deposit Contracts Liabilities DepositContractsLiabilities	293000	usd
CY2022Q2	curr	Common Stock And Common Stock Equivalents CommonStockAndCommonStockEquivalents	69868502000	shares
	curr	Request For Conversion Description Convertible RequestForConversionDescriptionConvertible	the Company purchased Convertible Loans (“Loans”) from ReLeaf Europe B.V. (“ReLeaf”) in the amount of $0.5 million which shall bear interest at 6% per annum and shall become due and payable to the Company at the earlier of the conversion date, the date when the Loans are repaid or at the maturity date of October 31, 2021 (“Maturity Date”). In the event of conversion by the Company, the outstanding amount of the Loans and any unpaid accrued interest shall be converted into shares of ReLeaf (“Shares”) based on a price per share on a post money valuation of $10.9 million.
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	80000.00	usd
CY2022Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	2000000.00	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	4730000	usd
	curr	Impairment Loss ImpairmentLoss	4620000	usd
	curr	Contingent Consideration Liabilitiespolicytextblock ContingentConsiderationLiabilitiespolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Certain of the Company’s asset and business acquisitions involve the potential for future payment of consideration to third-parties and former selling stockholders in amounts determined upon attainment of revenue milestones, from product sales, as applicable. The fair value of such liabilities is determined using unobservable inputs. These inputs include the estimated amount and timing of projected cash flows and the risk-adjusted discount rate used to present value the cash flows. These obligations are referred to as contingent consideration.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">ASC 805 requires that contingent consideration be estimated and recorded at fair value as of the acquisition date as part of the total consideration transferred. Contingent consideration is an obligation of the acquirer to transfer additional assets or equity interests to the selling stockholders in the future if certain future events occur or conditions are met, such as the attainment of product development milestones. Contingent consideration also includes additional future payments to selling stockholders based on achievement of components of earnings, such as “earn-out” provisions or percentage of future revenues, including royalties paid to the selling shareholders based on a percentage of revenues generated from the Sera Labs’ products.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The fair value of contingent consideration after the acquisition date is reassessed by the Company as changes in circumstances and conditions occur, with the subsequent change in fair value recorded in the consolidated statements of operations. Changes in key assumptions can materially affect the estimated fair value of contingent consideration liabilities and, accordingly, the resulting gain or loss that the Company records in its unaudited condensed consolidated financial statements. See Note 19 – Business Combination for additional information.</p>
	curr	Cure Pharmaceutical Revenuepolicytexkblock CurePharmaceuticalRevenuepolicytexkblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Cure Pharmaceutical derives revenues from two primary sources: products and services. Product revenue includes the shipment of products according to agreements with Cure Pharmaceutical’s customers. Services include research and development contracts for the development of OTF products utilizing Cure Pharmaceutical’s CureFilm Technology or our other proprietary technologies. Cure Pharmaceutical’s contracts with customers rarely contain multiple performance obligations. For these contracts, Cure Pharmaceutical accounts for individual performance obligations separately if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. Standalone selling prices are typically estimated based on observable transactions when these services are sold on a standalone basis.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Cure Pharmaceutical’s formulation and product development income include services for the development of OTF products utilizing our CureFilm Technology. Our development contracts have up to four phases. Revenue is recognized based on progress toward completion of the performance obligation in each phase. The method to measure progress toward completion requires judgment and is based on the nature of the products or services to be provided. Cure Pharmaceutical generally uses the input method to measure progress for its contracts because it best depicts the transfer of assets to the customer, which occurs as we incur costs for the contracts. Under the cost-to-cost measure of progress, the progress toward completion is measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation. Revenue is recorded proportionally as costs are incurred. Costs to fulfill these obligations mainly include materials, labor, supplies and consultants.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.35pt; TEXT-INDENT: 33.4pt; text-align:justify;">Cure Pharmaceutical entered into a Collaboration and Joint Development Agreement (“Agreement”) with Medolife Rx (“Medolife”) on February 1, 2021 (“Effective Date”) for Medolife to produce Medolife Products (“Products”) in Cure Pharmaceutical’s cGMP facility. The term of this agreement is five (5) years from the Effective Date (“Term”). Medolife is required to pay $0.3 million to assist in completing the jointly developed production line at the facility. In addition, Cure Pharmaceutical will produce Products on behalf of Medolife and will grant access to Medolife for a joint production area within the facility for the Term of this Agreement. The Company has determined that there are no distinct obligations for the $0.3 million and Cure Pharmaceutical does have further obligations as stated in the Agreement, thus the Company recognized the revenue monthly over the Term, beginning February 1, 2021. </p>
	curr	Sera Labs Revenuepolicytexkblock SeraLabsRevenuepolicytexkblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Sera Labs recognizes revenue as, or when, we satisfy performance obligations under a contract. We account for a contract when the parties approved the contract and are committed to perform on it, the rights of each party and the payment terms are identified, the contract has commercial substance and it is probable that we will collect substantially all of the consideration. A performance obligation is a promise in a contract to transfer a distinct good or service, or a series of distinct goods or services, to a customer. The transaction price of a contract must be allocated to each performance obligation and recognized as the performance obligation is satisfied. In essence, we recognize revenue when or as control of the promised goods or services transfer to the customer.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.35pt; TEXT-INDENT: 45px; text-align:justify;">Revenue from eCommerce sales, including direct-to-consumer sales, are recognized upon shipment of merchandise. We also elected to adopt the practical expedient related to shipping and handling fees which allows us to account for shipping and handling activities that occur after control of the related good transfers as fulfillment activities instead of assessing such activities as performance obligations. Therefore, shipping and handling activities are considered part of the Company’s obligation to transfer the products and therefore are recorded as direct selling expenses, as incurred. Shipping revenue are recorded upon delivery to the customer.</p>
	curr	Practical Expedients And Exemptionspolicytextblock PracticalExpedientsAndExemptionspolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The Company has elected certain practical expedients and policy elections as permitted under ASC Topic 606 as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">The Company adopted the practical expedient related to not adjusting the promised amount of consideration for the effects of a significant financing component if the period between transfer of product and customer payment is expected to be less than one year at the time of contract inception;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">The Company made the accounting policy election to exclude any sales and similar taxes from the transaction price;</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">·</span></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">The Company adopted the practical expedient not to disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less</p></td></tr></tbody></table>
	curr	Sales Taxpolicytextblock SalesTaxpolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The transaction price is the amount of consideration to which the Company expects to be entitled in exchange for transferring the promised goods or services to a customer, excluding sales taxes. The net amount of sales tax payable to the taxation authority is included sales tax payable in the unaudited condensed consolidated balance sheets.</p>
	curr	Sales Returns Discounts And Warrantiespolicytextblock SalesReturnsDiscountsAndWarrantiespolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Sales returns, discount and warranties are considered variable consideration under ASC 606. The Company reduces revenue for estimated future returns, discounts and warranties which may occur with distributors and retailers. When evaluating the adequacy of sales returns, discounts and warranties, the Company analyzes the following: historical credit allowances, current sell-through of inventory of the Company’s products, current trends in retail industry, changes in customer demand, acceptance of products, and other related factors.</p>
	curr	Cost To Obtain A Contractpolicytextblock CostToObtainAContractpolicytextblock	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The Company pays sales commission to its employees and outside sales representatives for contracts that they obtain relating to wholesale and personal protective equipment. The Company applies the optional practical expedient to immediately expense costs to obtain a contract if the amortization period of the asset that would have been recognized is one year or less. As such, sales commissions are immediately recognized as an expense and included as part of sales and marketing expenses.</p>
	curr	Contract Liabilitiespolicytextblcok ContractLiabilitiespolicytextblcok	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Advance payments and billings in excess of revenue recognized represent contract liabilities and are recorded as deferred revenues when customers remit contractual cash payments in advance before satisfying performance obligations under contractual arrangements. Contract liabilities are derecognized when revenue is recognized, and the performance obligation is satisfied. Advance payments and billings in excess of revenue recognized are included in deferred revenue, which is classified as current or noncurrent based on the timing of when the Company expects to recognize revenue. At June 30, 2022 and December 31, 2021, we had contract liabilities of $0.2 million and $0.3 million, respectively.</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">Contract liabilities is made up of the following as of June 30, 2022 and December 31, 2021 (in thousands):</p><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>June 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">Customer deposits for commercial products</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">$</p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 172</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">$</p></td><td class="ffcell"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"> 293</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Total contract liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">172</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">293</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The following table summarizes the changes in contract liabilities during the six months ended June 30, 2022 and year ended December 31, 2021 (in thousands):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">994</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">435</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Customer deposits returned</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(713 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Transfers to revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(208 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Contract liabilities held for sale</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(215 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at December 31, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">293</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Additions</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">26</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Customer deposits returned</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(45 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Transfers to revenue</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(84 </td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 13.7pt">Contract liabilities held for sale</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(18 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Balance at June 30, 2022</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">172</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q2	us-gaap	Deferred Revenue DeferredRevenue	200000	usd
CY2021Q4	us-gaap	Deferred Revenue DeferredRevenue	300000	usd
CY2021	curr	Contract Liabilities Beginning Balance ContractLiabilitiesBeginningBalance	994000	usd
CY2021	curr	Additions To Contract Liabilities AdditionsToContractLiabilities	435000	usd
CY2021	curr	Customer Deposits Returned CustomerDepositsReturned	-713000	usd
CY2021	curr	Transfers To Revenue TransfersToRevenue	-208000	usd
CY2021	curr	Contract Liabilities Asset Sale ContractLiabilitiesAssetSale	-215000	usd
	curr	Contract Liabilities Beginning Balance ContractLiabilitiesBeginningBalance	293000	usd
	curr	Additions To Contract Liabilities AdditionsToContractLiabilities	26000	usd
	curr	Customer Deposits Returned CustomerDepositsReturned	-45000	usd
	curr	Transfers To Revenue TransfersToRevenue	-84000	usd
	curr	Contract Liabilities Asset Sale ContractLiabilitiesAssetSale	-18000	usd
	curr	Contract Liabilities Ending Balance ContractLiabilitiesEndingBalance	172000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	80000.00	usd
	us-gaap	Advertising Expense AdvertisingExpense	400000	usd
CY2022Q2	curr	Advertising Expense1 AdvertisingExpense1	1000000.0	usd
	curr	Advertising Expense1 AdvertisingExpense1	1600000	usd
CY2022Q2	curr	Research And Development Expenses1 ResearchAndDevelopmentExpenses1	200000	usd
	curr	Research And Development Expenses1 ResearchAndDevelopmentExpenses1	500000	usd
CY2022Q2	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	700000	usd
	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1300000	usd
CY2022Q2	curr	Valuation Allowance Percentage ValuationAllowancePercentage	1	pure
CY2021Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-1321000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-14770000	usd
CY2020Q4	curr	Outstanding Contingent Consideration Liability OutstandingContingentConsiderationLiability	3200000	usd
CY2022Q2	curr	Fair Value Of Contingent Stock Consideration FairValueOfContingentStockConsideration	595000	usd
CY2022Q2	curr	Fair Value Of Series A Note FairValueOfSeriesANote	3100000	usd
CY2022Q2	curr	Fair Value Of Series B Note FairValueOfSeriesBNote	6473000	usd
CY2021Q4	curr	Fair Value Of Contingent Stock Consideration FairValueOfContingentStockConsideration	1430000	usd
CY2021Q4	curr	Fair Value Of Series A Note FairValueOfSeriesANote	3075000	usd
CY2021Q4	curr	Fair Value Of Series B Note FairValueOfSeriesBNote	6857000	usd
CY2021Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	9932000	usd
	curr	Changes In Fair Value Of Series A Note ChangesInFairValueOfSeriesANote	25000	usd
	curr	Change In Fair Value Of Series B Notes ChangeInFairValueOfSeriesBNotes	282000	usd
	curr	Conversion Of Series B Notes ConversionOfSeriesBNotes	-666000	usd
CY2022Q2	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	9573000	usd
	curr	Stock Price StockPrice	0.26
CY2021	curr	Stock Price StockPrice	0.36
	curr	Conversion Price ConversionPrice	1.32
CY2021	curr	Conversion Price ConversionPrice	1.32
	curr	Interest Rate InterestRate	0.18	pure
CY2021	curr	Interest Rate InterestRate	0.18	pure
	curr	Gain Loss From Change In Fair Value Of Series A And B Convertible Notes GainLossFromChangeInFairValueOfSeriesAAndBConvertibleNotes	-310000	usd
	curr	Gain Loss From Change In Fair Value Of Series A And B Convertible Notes GainLossFromChangeInFairValueOfSeriesAAndBConvertibleNotes	340000	usd
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-4492000	usd
CY2022Q2	curr	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	69868502000	shares
CY2021Q2	curr	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	59842904000	shares
	curr	Common Stock And Common Stock Equivalents CommonStockAndCommonStockEquivalents	69362563000	shares
	curr	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	48299751000	shares
	us-gaap	Guarantees Indemnifications And Warranties Policies GuaranteesIndemnificationsAndWarrantiesPolicies	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; TEXT-INDENT: 45px; text-align:justify;">The Company determines the accounting classification of warrants it issues, as either liability or equity classified, by first assessing whether the warrants meet liability classification in accordance with ASC 480-10, <em>Accounting for Certain Financial Instruments with Characteristics of both Liabilities and Equity</em>, then in accordance with ASC 815-40, <em>Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock</em>. Under ASC 480, warrants are considered liability classified if the warrants are mandatorily redeemable, obligate the Company to settle the warrants or the underlying shares by paying cash or other assets, or warrants that must or may require settlement by issuing variable number of shares. If warrants do not meet liability classification under ASC 480-10, the Company assesses the requirements under ASC 815-40, which states that contracts that require or may require the issuer to settle the contract for cash are liabilities recorded at fair value, irrespective of the likelihood of the transaction occurring that triggers the net cash settlement feature. If the warrants do not require liability classification under ASC 815-40, and in order to conclude equity classification, the Company also assesses whether the warrants are indexed to its common stock and whether the warrants are classified as equity under ASC 815-40 or other applicable GAAP. After all relevant assessments, the Company concludes whether the warrants are classified as liability or equity. Liability classified warrants require fair value accounting at issuance and subsequent to initial issuance with all changes in fair value after the issuance date recorded in the statements of operations. Equity classified warrants only require fair value accounting at issuance with no changes recognized subsequent to the issuance date. The Company does not have any liability classified warrants as of any period presented.</p>
	curr	Contingencies Contingencies	<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0.7pt; TEXT-INDENT: 35.3pt; text-align:justify;">We are exposed to claims and litigation arising in the ordinary course of business and use various methods to resolve these matters in a manner that we believe serves the best interest of our stockholders and other constituents. When a loss is probable, we record an accrual based on the reasonably estimable loss or range of loss. When no point of loss is more likely than another, we record the lowest amount in the estimated range of loss and, if material, disclose the estimated range of loss. We do not record liabilities for reasonably possible loss contingencies, but we do disclose a range of reasonably possible losses if they are material and we are able to estimate such a range. If we cannot provide a range of reasonably possible losses, we explain the factors that prevent us from determining such a range. Historically, adjustments to our estimates have not been material. We believe the recorded reserves in our unaudited condensed consolidated financial statements are adequate in light of the probable and estimable liabilities. We do not believe that any of these identified claims or litigation will be material to our results of operations, cash flows, or financial condition. Gain contingencies are recorded when the ultimate resolution of the contingency is resolved. </p>
CY2022Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-6931000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-310000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-8487000	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-2845000	usd
CY2022Q2	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-2688000	usd
CY2021Q2	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-1011000	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-6283000	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-1647000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-9619000	usd
CY2021Q2	curr	Common Stock And Common Stock Equivalents CommonStockAndCommonStockEquivalents	59842904000	shares
	curr	Weighted Average Number Of Shares Outstanding Basic And Diluted WeightedAverageNumberOfSharesOutstandingBasicAndDiluted	69362563000	shares
	curr	Common Stock And Common Stock Equivalents CommonStockAndCommonStockEquivalents	48299751000	shares
CY2022Q2	curr	Continuing Operations Per Share ContinuingOperationsPerShare	-0.10
CY2021Q2	curr	Continuing Operations Per Share ContinuingOperationsPerShare	-0.00
	curr	Continuing Operations Per Share ContinuingOperationsPerShare	-0.12
	curr	Continuing Operations Per Share ContinuingOperationsPerShare	-0.06
CY2022Q2	curr	Disposal Group Per Share DisposalGroupPerShare	-0.04
CY2021Q2	curr	Disposal Group Per Share DisposalGroupPerShare	-0.02
	curr	Disposal Group Per Share DisposalGroupPerShare	-0.09
	curr	Disposal Group Per Share DisposalGroupPerShare	-0.03
	curr	Vested Stock Options From The Companys2017 Equity Incentive Plan VestedStockOptionsFromTheCompanys2017EquityIncentivePlan	3864446	shares
	curr	Vested Stock Options From The Companys2017 Equity Incentive Plan VestedStockOptionsFromTheCompanys2017EquityIncentivePlan	3471304	shares
	curr	Warrants Shares WarrantsShares	615530	shares
	curr	Warrants Shares WarrantsShares	2264091	shares
	curr	Shares To Be Issued Upon Conversion Of Convertible Payable SharesToBeIssuedUponConversionOfConvertiblePayable	115047	shares
	curr	Shares To Be Issued Upon Conversion Of Convertible Payable SharesToBeIssuedUponConversionOfConvertiblePayable	115047	shares
	curr	Total Anti Dilutive Shares TotalAntiDilutiveShares	4595023	shares
	curr	Total Anti Dilutive Shares TotalAntiDilutiveShares	5850442	shares
CY2022Q2	curr	Maximum Share Receivale Upon Achievement Of Certain Sales Milestones MaximumShareReceivaleUponAchievementOfCertainSalesMilestones	5988024	shares
	curr	Common Stock Conversion Price CommonStockConversionPrice	1.32
CY2022Q2	curr	Customer Billed Accounts Receivable CustomerBilledAccountsReceivable	625000	usd
CY2021Q4	curr	Customer Billed Accounts Receivable CustomerBilledAccountsReceivable	437000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	80000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	80000	usd
CY2022Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	545000	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	357000	usd
CY2022Q2	us-gaap	Prepaid Insurance PrepaidInsurance	126000	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	302000	usd
CY2022Q2	curr	Prepaid Deposit For Inventory PrepaidDepositForInventory	105000	usd
CY2021Q4	curr	Prepaid Deposit For Inventory PrepaidDepositForInventory	89000	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	18000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	10000	usd
CY2022Q2	us-gaap	Other Assets Current OtherAssetsCurrent	120000	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	46000	usd
CY2022Q2	curr	Prepaid Expenses And Other Assets PrepaidExpensesAndOtherAssets	369000	usd
CY2021Q4	curr	Prepaid Expenses And Other Assets PrepaidExpensesAndOtherAssets	447000	usd
CY2022Q2	curr	Finance Lease Right Of Use Asset Assets Held For Sale FinanceLeaseRightOfUseAssetAssetsHeldForSale	34000	usd
CY2021Q4	curr	Finance Lease Right Of Use Asset Assets Held For Sale FinanceLeaseRightOfUseAssetAssetsHeldForSale	40000	usd
CY2022Q2	curr	Goodwill Assets Held For Sale GoodwillAssetsHeldForSale	4450000	usd
CY2021Q4	curr	Goodwill Assets Held For Sale GoodwillAssetsHeldForSale	9178000	usd
CY2022Q2	curr	Intangible Assets Net Excluding Goodwill Assets Held For Sale IntangibleAssetsNetExcludingGoodwillAssetsHeldForSale	13652000	usd
CY2022Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	0	usd
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	0	usd
CY2022Q2	curr	Inventory Packaging Components InventoryPackagingComponents	0	usd
CY2021Q4	curr	Inventory Packaging Components InventoryPackagingComponents	0	usd
CY2022Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	0	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	0	usd
CY2022Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	748000	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	730000	usd
CY2022Q2	us-gaap	Inventory Gross InventoryGross	748000	usd
CY2021Q4	us-gaap	Inventory Gross InventoryGross	730000	usd
CY2022Q2	us-gaap	Inventory Adjustments InventoryAdjustments	-99000	usd
CY2021Q4	us-gaap	Inventory Adjustments InventoryAdjustments	-109000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	649000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	621000	usd
CY2022Q2	curr	Inventory Reserves InventoryReserves	6000.000	usd
CY2021Q2	curr	Inventory Reserves InventoryReserves	3000.000	usd
	curr	Inventory Reserves InventoryReserves	6000.000	usd
	curr	Inventory Reserves InventoryReserves	3000.000	usd
	us-gaap	Schedule Of Closed Block Assets And Liabilities ScheduleOfClosedBlockAssetsAndLiabilities	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Carrying amounts of assets included as part of assets held for sale (in thousands):</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Inventory, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">223</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">243</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Prepaid expenses and other assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">81</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">97</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Property and equipment, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,760</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,837</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Finance lease right-of-use assets, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">34</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Goodwill, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">4,450</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9,178</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Intellectual property and patents, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">13,652</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14,401</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">In-process research and development, net</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">329</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">329</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Other assets</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">35</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">35</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 33.75pt">Total assets classified as assets held for sale in the unaudited condensed consolidated balance sheet</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">20,564</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">26,160</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Carrying amounts of liabilities included as part of liabilities held for sale:</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Accrued expenses</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">383</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">268</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Finance lease payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">34</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">40</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Notes payable</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,350</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 22.5pt">Contract liabilities</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">238</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">215</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 33.75pt">Total liabilities classified as liabilities held for sale in the unaudited condensed consolidated balance sheet</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">4,005</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">523</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q2	curr	Inventory Net Assets Held For Sale InventoryNetAssetsHeldForSale	223000	usd
CY2021Q4	curr	Inventory Net Assets Held For Sale InventoryNetAssetsHeldForSale	243000	usd
CY2022Q2	curr	Prepaid Expense And Other Assets Current Assets Held For Sale PrepaidExpenseAndOtherAssetsCurrentAssetsHeldForSale	81000	usd
CY2021Q4	curr	Prepaid Expense And Other Assets Current Assets Held For Sale PrepaidExpenseAndOtherAssetsCurrentAssetsHeldForSale	97000	usd
CY2022Q2	curr	Property Plant And Equipment Net Assets Held For Sale PropertyPlantAndEquipmentNetAssetsHeldForSale	1760000	usd
CY2021Q4	curr	Property Plant And Equipment Net Assets Held For Sale PropertyPlantAndEquipmentNetAssetsHeldForSale	1837000	usd
CY2021Q4	curr	Intangible Assets Net Excluding Goodwill Assets Held For Sale IntangibleAssetsNetExcludingGoodwillAssetsHeldForSale	14401000	usd
CY2022Q2	curr	In Process Research And Development Net InProcessResearchAndDevelopmentNet	329000	usd
CY2021Q4	curr	In Process Research And Development Net InProcessResearchAndDevelopmentNet	329000	usd
CY2022Q2	curr	Other Assets Assets Held For Sale OtherAssetsAssetsHeldForSale	35000	usd
CY2021Q4	curr	Other Assets Assets Held For Sale OtherAssetsAssetsHeldForSale	35000	usd
CY2022Q2	curr	Total Assets Classified As Assets Held For Sale In The Consolidated Balance Sheet TotalAssetsClassifiedAsAssetsHeldForSaleInTheConsolidatedBalanceSheet	20564000	usd
CY2021Q4	curr	Total Assets Classified As Assets Held For Sale In The Consolidated Balance Sheet TotalAssetsClassifiedAsAssetsHeldForSaleInTheConsolidatedBalanceSheet	26160000	usd
CY2022Q2	curr	Accrued Utilities Current Assets Held For Sale AccruedUtilitiesCurrentAssetsHeldForSale	383000	usd
CY2021Q4	curr	Accrued Utilities Current Assets Held For Sale AccruedUtilitiesCurrentAssetsHeldForSale	268000	usd
CY2022Q2	curr	Finance Lease Liability Current Assets Held For Sale FinanceLeaseLiabilityCurrentAssetsHeldForSale	34000	usd
CY2021Q4	curr	Finance Lease Liability Current Assets Held For Sale FinanceLeaseLiabilityCurrentAssetsHeldForSale	40000	usd
CY2022Q2	curr	Notes Payable Current Assets Held For Sale NotesPayableCurrentAssetsHeldForSale	3350000	usd
CY2021Q4	curr	Notes Payable Current Assets Held For Sale NotesPayableCurrentAssetsHeldForSale	0	usd
CY2022Q2	curr	Deposit Contracts Liabilities Assets Held For Sale DepositContractsLiabilitiesAssetsHeldForSale	238000	usd
CY2021Q4	curr	Deposit Contracts Liabilities Assets Held For Sale DepositContractsLiabilitiesAssetsHeldForSale	215000	usd
CY2022Q2	curr	Total Liabilities Classified As Liabilities Held For Sale In The Consolidated Balance Sheet TotalLiabilitiesClassifiedAsLiabilitiesHeldForSaleInTheConsolidatedBalanceSheet	4005000	usd
CY2021Q4	curr	Total Liabilities Classified As Liabilities Held For Sale In The Consolidated Balance Sheet TotalLiabilitiesClassifiedAsLiabilitiesHeldForSaleInTheConsolidatedBalanceSheet	523000	usd
CY2022Q2	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	20600000	usd
CY2022Q2	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	4000000.0	usd
CY2022Q2	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilities	3400000	usd
	curr	Consideration To Be Received From The Buyer ConsiderationToBeReceivedFromTheBuyer	20000000.0	usd
	curr	Additional Impairment Loss AdditionalImpairmentLoss	2000000.0	usd
CY2022Q2	curr	Estimated Costs To Sell Charged To Goodwill EstimatedCostsToSellChargedToGoodwill	90000.00	usd
CY2022Q2	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	97000	usd
CY2021Q2	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	0	usd
	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	108000	usd
	curr	Product Sales Net Of Discounts And Refunds Assets Held For Sale ProductSalesNetOfDiscountsAndRefundsAssetsHeldForSale	135000	usd
	curr	Consulting Research Development Income Assets Held For Sale ConsultingResearchDevelopmentIncomeAssetsHeldForSale	58000	usd
CY2021Q2	curr	Consulting Research Development Income Assets Held For Sale ConsultingResearchDevelopmentIncomeAssetsHeldForSale	25000	usd
CY2022Q2	curr	Consulting Research Development Income Assets Held For Sale ConsultingResearchDevelopmentIncomeAssetsHeldForSale	58000	usd
	curr	Consulting Research Development Income Assets Held For Sale ConsultingResearchDevelopmentIncomeAssetsHeldForSale	52000	usd
CY2022Q2	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	24000	usd
CY2021Q2	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	17000	usd
	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	40000	usd
	curr	Shipping And Other Sales Assets Held For Sale ShippingAndOtherSalesAssetsHeldForSale	39000	usd
CY2022Q2	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	179000	usd
CY2021Q2	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	42000	usd
	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	206000	usd
	curr	Revenues Assets Held For Sale RevenuesAssetsHeldForSale	226000	usd
CY2022Q2	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	59000	usd
CY2021Q2	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	49000	usd
	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	75000	usd
	curr	Cost Of Goods And Services Sold Assets Held For Sale CostOfGoodsAndServicesSoldAssetsHeldForSale	181000	usd
CY2022Q2	curr	Gross Profit Loss GrossProfitLoss	120000	usd
CY2021Q2	curr	Gross Profit Loss GrossProfitLoss	-7000	usd
	curr	Gross Profit Loss GrossProfitLoss	131000	usd
	curr	Gross Profit Loss GrossProfitLoss	45000	usd
CY2022Q2	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	202000	usd
CY2021Q2	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	699000	usd
	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	464000	usd
	curr	Research And Development Expense Assets Held For Sale ResearchAndDevelopmentExpenseAssetsHeldForSale	1343000	usd
CY2022Q2	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	606000	usd
CY2021Q2	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	305000	usd
	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	1222000	usd
CY2022Q2	us-gaap	Notes Receivable Net NotesReceivableNet	200000	usd
CY2021Q4	us-gaap	Notes Receivable Net NotesReceivableNet	200000	usd
CY2022Q2	curr	Valuation Reserves ValuationReserves	400000	usd
CY2021Q4	curr	Valuation Reserves ValuationReserves	400000	usd
CY2022Q2	curr	Loan Payable Less Current Portion LoanPayableLessCurrentPortion	0	usd
CY2021Q4	curr	Loan Payable Less Current Portion LoanPayableLessCurrentPortion	0	usd
CY2022Q2	curr	Interest Expenses InterestExpenses	3000.000	usd
	curr	Selling General And Administrative Expense Assets Held For Sale SellingGeneralAndAdministrativeExpenseAssetsHeldForSale	349000	usd
CY2022Q2	curr	Impairment Of Goodwill ImpairmentOfGoodwill	2000000	usd
CY2021Q2	curr	Impairment Of Goodwill ImpairmentOfGoodwill	0	usd
	curr	Impairment Of Goodwill ImpairmentOfGoodwill	4728000	usd
	curr	Impairment Of Goodwill ImpairmentOfGoodwill	0	usd
CY2022Q2	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	2808000	usd
CY2021Q2	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	1004000	usd
	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	6414000	usd
	curr	Operating Expenses Assets Held For Sale OperatingExpensesAssetsHeldForSale	1692000	usd
CY2022Q2	curr	Net Loss NetLoss	-2688000	usd
CY2021Q2	curr	Net Loss NetLoss	-1011000	usd
	curr	Net Loss NetLoss	-6283000	usd
	curr	Net Loss NetLoss	-1647000	usd
CY2022Q2	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
CY2021Q2	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
	curr	Income Tax Expense Benefit Assets Held For Sale IncomeTaxExpenseBenefitAssetsHeldForSale	0	usd
CY2022Q2	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	-2688000	usd
CY2021Q2	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	-1011000	usd
	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	-6283000	usd
	curr	Net Loss Before Income Taxes NetLossBeforeIncomeTaxes	-1647000	usd
CY2022Q2	us-gaap	Sale Leaseback Transaction Accumulated Depreciation SaleLeasebackTransactionAccumulatedDepreciation	4000	usd
CY2021Q4	us-gaap	Sale Leaseback Transaction Accumulated Depreciation SaleLeasebackTransactionAccumulatedDepreciation	3000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4000	usd
CY2022Q2	curr	Allowance For Doubtful Accounts Receivable1 AllowanceForDoubtfulAccountsReceivable1	0	usd
CY2021Q4	curr	Allowance For Doubtful Accounts Receivable1 AllowanceForDoubtfulAccountsReceivable1	0	usd
CY2022Q2	curr	Current Portion Of Note Receivable CurrentPortionOfNoteReceivable	0	usd
CY2021Q4	curr	Current Portion Of Note Receivable CurrentPortionOfNoteReceivable	0	usd
CY2022Q2	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	3095000	usd
CY2021Q4	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	3074000	usd
	curr	Weighted Average Exercise Price D3 WeightedAverageExercisePriceD3	1.99
CY2022Q2	us-gaap	Goodwill Gross GoodwillGross	4690000	usd
CY2021Q4	us-gaap	Goodwill Gross GoodwillGross	4690000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	3072000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	10182000	usd
CY2022Q2	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	8014000	usd
CY2021Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	15133000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1554000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2885000	usd
CY2022Q2	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	6460000	usd
CY2021Q4	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	12248000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4620000	usd
CY2022Q2	us-gaap	Capital Leases Income Statement Amortization Expense CapitalLeasesIncomeStatementAmortizationExpense	600000	usd
CY2021Q2	us-gaap	Capital Leases Income Statement Amortization Expense CapitalLeasesIncomeStatementAmortizationExpense	600000	usd
	us-gaap	Capital Leases Income Statement Amortization Expense CapitalLeasesIncomeStatementAmortizationExpense	1200000	usd
	us-gaap	Capital Leases Income Statement Amortization Expense CapitalLeasesIncomeStatementAmortizationExpense	1200000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	384000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	653000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	481000	usd
CY2022Q2	curr	Total Amortization TotalAmortization	1518000	usd
CY2022Q2	curr	Investment In Releaf Europe Bv InvestmentInReleafEuropeBv	566000	usd
CY2021Q4	curr	Investment In Releaf Europe Bv InvestmentInReleafEuropeBv	566000	usd
CY2022Q2	curr	Investment Valuation Reserves InvestmentValuationReserves	-350000	usd
CY2021Q4	curr	Investment Valuation Reserves InvestmentValuationReserves	-350000	usd
CY2022Q2	curr	Investment Net InvestmentNet	216000	usd
CY2021Q4	curr	Investment Net InvestmentNet	216000	usd
	curr	Interest Expenses InterestExpenses	6000.000	usd
CY2022Q2	curr	Accounts Payable Factoring AccountsPayableFactoring	0	usd
CY2021Q4	curr	Accounts Payable Factoring AccountsPayableFactoring	1722000	usd
CY2022Q2	curr	Refunds And Returns Liability RefundsAndReturnsLiability	892000	usd
CY2021Q4	curr	Refunds And Returns Liability RefundsAndReturnsLiability	445000	usd
CY2022Q2	curr	Accrued Interest AccruedInterest	755000	usd
CY2021Q4	curr	Accrued Interest AccruedInterest	390000	usd
CY2022Q2	curr	Accrued Payroll AccruedPayroll	241000	usd
CY2021Q4	curr	Accrued Payroll AccruedPayroll	178000	usd
CY2022Q2	us-gaap	Accrued Vacation Current And Noncurrent AccruedVacationCurrentAndNoncurrent	67000	usd
CY2021Q4	us-gaap	Accrued Vacation Current And Noncurrent AccruedVacationCurrentAndNoncurrent	173000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	458000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	243000	usd
CY2022Q2	curr	Sales Tax Payable SalesTaxPayable	321000	usd
CY2021Q4	curr	Sales Tax Payable SalesTaxPayable	334000	usd
CY2022Q2	curr	Accrued Expenses Net AccruedExpensesNet	2734000	usd
CY2021Q4	curr	Accrued Expenses Net AccruedExpensesNet	3485000	usd
	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	300000	usd
CY2021	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	80000.00	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	100000	usd
	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	40000.00	usd
CY2022Q2	us-gaap	Loans Payable LoansPayable	48000	usd
CY2021Q4	us-gaap	Loans Payable LoansPayable	235000	usd
CY2021Q2	curr	Interest Expenses InterestExpenses	1000.000	usd
	curr	Interest Expenses InterestExpenses	3000.000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	3129000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2877000	usd
CY2021Q4	curr	Interest Rate InterestRate	0.10	pure
CY2021Q1	curr	Interest Rate InterestRate	0.10	pure
CY2021Q3	curr	Interest Rate InterestRate	0.10	pure
CY2021Q4	curr	Interest Rate InterestRate	0.10	pure
CY2021Q4	curr	Interest Rate InterestRate	0.10	pure
CY2021Q4	curr	Interest Rate InterestRate	0.10	pure
CY2022Q1	curr	Interest Rate InterestRate	0.10	pure
CY2022Q2	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	550000	usd
CY2021Q4	curr	Convertible Promissory Notes ConvertiblePromissoryNotes	550000	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	550000	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	550000	usd
	curr	Scheduleoffair Value Of Convertible Promissory Notes Tabletextblock ScheduleoffairValueOfConvertiblePromissoryNotesTabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series A subordinated convertible note at fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,095</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3,074</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Series B subordinated convertible note at fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,478</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">11,858</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Total convertible promissory notes</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14,573</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">14,932</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Less: Investor Note offset – Series B Note</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(5,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(5,000 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 11.25pt">Carrying value of convertible promissory notes at fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9,573</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">9,932</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Less: current portion of convertible promissory notes at fair value</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(9,573 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(9,932 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 11.25pt; text-align:justify;">Convertible promissory notes, less current portion</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">-</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q2	us-gaap	Convertible Subordinated Debt ConvertibleSubordinatedDebt	11478000	usd
CY2021Q4	us-gaap	Convertible Subordinated Debt ConvertibleSubordinatedDebt	11858000	usd
CY2022Q2	us-gaap	Commercial Paper CommercialPaper	14573000	usd
CY2021Q4	us-gaap	Commercial Paper CommercialPaper	14932000	usd
CY2022Q2	curr	Less Investor Note Offset LessInvestorNoteOffset	-5000000	usd
CY2021Q4	curr	Less Investor Note Offset LessInvestorNoteOffset	-5000000	usd
CY2022Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	9573000	usd
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	9932000	usd
CY2022Q2	curr	Less Current Portion Of Convertible Promissory Notes At Fair Value LessCurrentPortionOfConvertiblePromissoryNotesAtFairValue	9573000	usd
CY2021Q4	curr	Less Current Portion Of Convertible Promissory Notes At Fair Value LessCurrentPortionOfConvertiblePromissoryNotesAtFairValue	-9932000	usd
CY2022Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	0	usd
CY2020	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	1000000.0	usd
CY2020	curr	Remaining Balance Of Investor Note RemainingBalanceOfInvestorNote	5000000.0	usd
	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.18	pure
CY2020Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	1100000
CY2020	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.18	pure
	us-gaap	Debt Conversion Description DebtConversionDescription	The Investor will not have the right to convert any portion of a Convertible Notes, to the extent that, after giving effect to such conversion, the Investor (and other certain related parties) would beneficially own in excess of 4.99% of the shares of Common Stock outstanding immediately after giving effect to such conversion. This limit may, from time to time, be increased, up to 9.99%, or decreased
	curr	Warrant Exercisable Shares WarrantExercisableShares	363636	shares
	curr	Schedule Of Aggregated Fair Values Of The Warrants Tabletextblock ScheduleOfAggregatedFairValuesOfTheWarrantsTabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant assumptions (weighted-average):</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk-free interest rate at grant date</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.36</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected stock price volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">81.14</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected dividend payout</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected warrant life (in years)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected forfeiture rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table>
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0036	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.8114	pure
	curr	Expected Dividend Payout ExpectedDividendPayout	0	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y
	curr	Expected Forfeiture Rate ExpectedForfeitureRate	0	pure
CY2022Q2	curr	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Bc ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBC	615530	shares
	curr	Weighted Average Remaining Contractual Life Years WeightedAverageRemainingContractualLifeYears	P1Y
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	615530	shares
	curr	Number Of Warrants Exercisable Weighted Average Exercise Price NumberOfWarrantsExercisableWeightedAverageExercisePrice	1.99
CY2021Q4	curr	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Bc ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumberBC	1565447	shares
CY2021	curr	Weighted Average Exercise Price D3 WeightedAverageExercisePriceD3	2.18
CY2021	curr	Number Of Warrants Exercisable Weighted Average Exercise Price NumberOfWarrantsExercisableWeightedAverageExercisePrice	2.18
CY2022Q2	curr	Change In Warrant Value ChangeInWarrantValue	0	usd
CY2021Q2	curr	Change In Warrant Value ChangeInWarrantValue	0	usd
	curr	Change In Warrant Value ChangeInWarrantValue	0	usd
	curr	Change In Warrant Value ChangeInWarrantValue	0	usd
	curr	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding And Exercisable SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstandingAndExercisable	0	usd
	curr	Term Of Exercise Period TermOfExercisePeriod	P10Y
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	0	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	1100000	usd
CY2022Q2	curr	Compensation Expense To Restricted Shares CompensationExpenseToRestrictedShares	200000	usd
	curr	Compensation Expense To Restricted Shares CompensationExpenseToRestrictedShares	500000	usd
CY2021Q2	curr	Compensation Expense To Restricted Shares CompensationExpenseToRestrictedShares	500000	usd
	curr	Compensation Expense To Restricted Shares CompensationExpenseToRestrictedShares	1200000	usd
	curr	Schedule Of Nonvested Restricted Award Shares ScheduleOfNonvestedRestrictedAwardShares	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>June 30, 2021</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Significant assumptions (weighted-average):</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Risk-free interest rate at grant date</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.92</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected stock price volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">84.52</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected dividend payout</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected option life (in years)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">10</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Expected forfeiture rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table>
CY2022Q2	us-gaap	Other Commitment OtherCommitment	24000	usd
CY2022Q2	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	227000	usd
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Convertible Preferred Stock Shares Issued Upon Conversion ConvertiblePreferredStockSharesIssuedUponConversion	70011900	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	68201900	shares
CY2020Q4	curr	Upfront Payment In Cash UpfrontPaymentInCash	1000000.0	usd
	curr	Closing Merger Consideration Shares Shares ClosingMergerConsiderationSharesShares	6909091	shares
	curr	Contingent Consideration Shares Clawback Shares Shares ContingentConsiderationSharesClawbackSharesShares	5988024	shares
	curr	Aggregate Amount AggregateAmount	20000000	usd
	curr	Working Capital WorkingCapital	4000000.0	usd
CY2020Q4	curr	Potential Shares To Be Issued potentialSharesToBeIssued	5988024	shares
CY2020Q4	curr	Aggregate Maximum Milestones Amount AggregateMaximumMilestonesAmount	20000000	usd
CY2020Q4	curr	Fair Value Of Contingent Shares FairValueOfContingentShares	3100000	usd
CY2021	curr	Fair Value At June302022 FairValueAtJune302022	1430000	usd
	curr	Fair Value At June302022 FairValueAtJune302022	595000	usd
	curr	Net Change In Fair Valuefor The Six Months Ended June302022 NetChangeInFairValueforTheSixMonthsEndedJune302022	-835000	usd
	curr	Weighted Average Discount Rate WeightedAverageDiscountRate	0.1130	pure
	curr	Schedule Of Future Lease Paymentstabletextblock ScheduleOfFutureLeasePaymentstabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Years</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:11.25pt">2022 (remaining)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">67</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:11.25pt">2023</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">138</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:11.25pt">2024</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">46</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Undiscounted cash flow</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">251</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Effects of discounting</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">(24 </td><td style="PADDING-BOTTOM: 1px;width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lease liabilities recognized</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">227</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2022Q2	us-gaap	Other Commitment Due In Next Twelve Months OtherCommitmentDueInNextTwelveMonths	67000	usd
CY2022Q2	us-gaap	Other Commitment Due In Second Year OtherCommitmentDueInSecondYear	138000	usd
CY2022Q2	us-gaap	Other Commitment Due In Third Year OtherCommitmentDueInThirdYear	46000	usd
CY2022Q2	curr	Undiscounted Cash Flow UndiscountedCashFlow	251000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	210000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	257000	usd
CY2022Q2	curr	Right Of Use Lease Liabilities Current RightOfUseLeaseLiabilitiesCurrent	117000	usd
CY2021Q4	curr	Right Of Use Lease Liabilities Current RightOfUseLeaseLiabilitiesCurrent	104000	usd
CY2022Q2	curr	Right Of Use Lease Liability Noncurrent RightOfUseLeaseLiabilityNoncurrent	110000	usd
CY2021Q4	curr	Right Of Use Lease Liability Noncurrent RightOfUseLeaseLiabilityNoncurrent	174000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	227000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	278000	usd
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1130	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1130	pure
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4000	usd
	curr	Product Sales Net Of Discounts And Refunds ProductSalesNetOfDiscountsAndRefunds	3312000	usd
	curr	Shipping And Other Sales ShippingAndOtherSales	0	usd
CY2022Q2	us-gaap	Revenues Revenues	1123000	usd

Files In Submission

Name	View Source	Status
0001477932-22-006612-index-headers.html	Edgar Link	pending
0001477932-22-006612-index.html	Edgar Link	pending
0001477932-22-006612.txt	Edgar Link	pending
0001477932-22-006612-xbrl.zip	Edgar Link	pending
curr-20220630.xsd	Edgar Link	pending
curr_10q.htm	Edgar Link	pending
curr_ex311.htm	Edgar Link	pending
curr_ex312.htm	Edgar Link	pending
curr_ex321.htm	Edgar Link	pending
curr_ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
curr-20220630_cal.xml	Edgar Link	unprocessable
curr-20220630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
curr-20220630_pre.xml	Edgar Link	unprocessable
curr_10q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
curr-20220630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVRW
Avenir Wellness Solutions, Inc. Stock $avrw

2022 Q3 Form 10-Q Financial Statement

#000147793222006612 Filed on September 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVRW Avenir Wellness Solutions, Inc. Stock $avrw

2022 Q3 Form 10-Q Financial Statement

#000147793222006612 Filed on September 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVRW
Avenir Wellness Solutions, Inc. Stock $avrw